Mumbai-based longevity and preventive healthcare platform Vytalyou has successfully raised ₹8-10 crore in growth funding at a valuation of around ₹33 crore. According to reports from Business Standard, the investment was secured in August 2026 from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries. The funding will support the company's next phase of expansion as it looks to strengthen its presence in the Mumbai market and enter other major Indian cities in 2027.
As reported by Business Standard, Vytalyou currently operates a centre in Powai and is setting up centres in Juhu and Worli, creating a three-location Mumbai network. The company was founded by molecular oncologist Dr Chirantan Bose and radiologist Dr Preetesh Bhandari and was incorporated in September 2025. The founders bring specialized medical expertise to the platform's approach to preventive healthcare.
According to Business Standard, Vytalyou's model combines diagnostics with preventive healthcare, with a focus on identifying health risks early and extending an individual's 'healthspan'. The company's Predictive Longevity Evaluation combines blood investigations, ultrasound imaging, body-composition analysis and cardiovascular evaluation. Additionally, Vytalyou offers interventions including hyperbaric oxygen therapy, cryotherapy, photobiomodulation and regenerative therapies to provide comprehensive longevity-focused healthcare services.
